The Bionics Institute is pleased to announce the appointment of Mr Philip Binns as Chair of the Board.
Phil brings more than 30 years of leadership experience across the scientific and life sciences industries. He most recently served as President of Agilent Technologies’ Life Sciences and Applied Markets Group, retiring in April 2025 after a distinguished global career.
Phil has been a valued member of the Bionics Institute Board and brings deep expertise in technology, commercialisation and innovation. His experience working across the life sciences sector will help guide the Institute as it continues to translate cutting-edge research into medical technologies that transform lives.
Phil will be supported by Deputy Chair, Hannah Crawford whose leadership, financial acumen and strategic expertise have been instrumental in supporting the Institute’s growth and ensuring robust oversight across all areas.
It is an honour and privilege to take on the role of Chair of the Bionics Institute. The Institute has an exciting future, building on the many years of incredible innovations from our world class research team. I look forward to working with the team and our partners to further our mission of developing and bringing to clinic new life-changing diagnostics and therapies for people living with challenging medical conditions.
In addition to his role with the Bionics Institute, Phil is Chair of Epiminder Ltd, a board member of Lightcast Discovery Ltd, and serves as a National Advisory Councillor for the Australian Industry Group. He is also an active investor and mentor supporting early-stage technology companies.
